- Home
- NKX vs MGTX Comparison
NKX vs MGTX Comparison
Compare NKX & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKX
- MGTX
- Stock Information
- Founded
- NKX 2002
- MGTX 2015
- Country
- NKX United States
- MGTX United States
- Employees
- NKX N/A
- MGTX N/A
- Industry
- NKX Finance/Investors Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NKX Finance
- MGTX Health Care
- Exchange
- NKX Nasdaq
- MGTX Nasdaq
- Market Cap
- NKX 581.2M
- MGTX 515.7M
- IPO Year
- NKX N/A
- MGTX N/A
- Fundamental
- Price
- NKX $11.83
- MGTX $5.12
- Analyst Decision
- NKX
- MGTX Strong Buy
- Analyst Count
- NKX 0
- MGTX 2
- Target Price
- NKX N/A
- MGTX $24.00
- AVG Volume (30 Days)
- NKX 109.3K
- MGTX 658.4K
- Earning Date
- NKX 01-01-0001
- MGTX 05-13-2025
- Dividend Yield
- NKX 4.37%
- MGTX N/A
- EPS Growth
- NKX N/A
- MGTX N/A
- EPS
- NKX N/A
- MGTX N/A
- Revenue
- NKX N/A
- MGTX $34,508,000.00
- Revenue This Year
- NKX N/A
- MGTX $382.62
- Revenue Next Year
- NKX N/A
- MGTX $66.88
- P/E Ratio
- NKX N/A
- MGTX N/A
- Revenue Growth
- NKX N/A
- MGTX 203.23
- 52 Week Low
- NKX $9.78
- MGTX $3.85
- 52 Week High
- NKX $12.00
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- NKX 36.24
- MGTX 42.63
- Support Level
- NKX $11.76
- MGTX $4.82
- Resistance Level
- NKX $11.93
- MGTX $5.38
- Average True Range (ATR)
- NKX 0.08
- MGTX 0.36
- MACD
- NKX -0.02
- MGTX 0.02
- Stochastic Oscillator
- NKX 11.11
- MGTX 46.34
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.